pharma · Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · metastatic or unresectable, recurrent HNSCC
Createrna Science and
Wuhan Createrna Science and Technology Co., Ltd
Createrna Science and clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- shanghai, CN, London
- Employees
- 26
- Programs
- 51
- Drugs
- 87
- Patents
- 0
Createrna Science and projects
3 ClinicalTrials.gov programs sponsored by Createrna Science and.
Createrna Science and has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors
Wuhan Createrna Science and Technology Co., Ltd
Advanced Solid Tumors
1 trial -
A Study to evaluate the effect of a high-fat... for Healthy volunteer
Wuhan Createrna Science and Technology Co., Ltd
Healthy volunteer
1 trial -
DF-006-1001
Wuhan Createrna Science and Technology Co., Ltd
Chronic Hepatitis B
1 trial
Frequently asked questions
How many clinical projects does Createrna Science and have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.